Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis.

Neurol Neuroimmunol Neuroinflamm · 2022 · PMC9423710 · PMID 36038262

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

OLR1 levels in the 6 participants were within the range of the controls and showed a trend of decreasing in response to treatment with Tregs/IL-2.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.